Johnson and Johnson 2005 Annual Report Download - page 71

Download and view the complete annual report

Please find page 71 of the 2005 Johnson and Johnson annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 80

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80

Greiter AG offers a line of sunscreen, after-sun and self-tan products with its main brand,
PIZ BUIN®
. Products are sold throughout Europe, the Middle East, Africa and other markets.
Independence Technology, L.L.C. markets products and services that increase the
independence of people with disabilities. Products include the INDEPENDENCE®iBOT®
4000 Mobility System.
The Janssen-Cilag companies, which operate outside the U.S., market prescription pharma-
ceuticals. Among these are VELCADE®(bortezomib) for injection in oncology; EPREX®/ERYPO®
(Epoetin alfa) in hematology and nephrology; RISPERDAL®(risperidone) in psychiatry;
DUROGESIC®(fentanyl transdermal system) for pain management; PARIET®(rabeprazole
sodium) in gastroenterology; and SPORANOX®(itraconazole) for fungal infections.
Janssen, L.P. is focused on mental health and markets prescription medications that treat
schizophrenia and bipolar mania. Leading products include RISPERDAL®(risperidone) and
RISPERDAL®CONSTA®(risperidone) long-acting injection.
Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer
Companies, Inc. develops and markets baby care, wound care and skin care products that
address the needs of consumers and health care professionals and incorporate the latest
innovations. The portfolio includes heritage brands JOHNSON’S®Baby and BAND-AID®
Brand, as well as leading skin care brands such as AVEENO®and CLEAN & CLEAR®
.
Johnson & Johnson Development Corporation (JJDC) makes equity investments in early-
stage venture and publicly traded health care companies. Portfolio companies include those
in the fields of pharmaceuticals, biotechnology, medical and surgical devices, health care
information technology, diagnostics and consumer products. JJDC also leads and manages
internal investments in selected promising technologies.
Johnson & Johnson Gateway, LLC develops and manages a Web-based resource of
information created for health care professionals by Johnson & Johnson medical devices
and diagnostics companies. Product information, clinical content, professional education
and patient materials are available in a global Internet destination, which in many
countries includes e-commerce transaction and inquiry capabilities.
Johnson & Johnson Health Care Systems Inc. provides account management and customer
support services to key health care customers, including hospital systems and group pur-
chasing organizations, leading health plans, pharmacy benefit managers, and government
health care institutions. The company also provides contract management, logistics and supply
chain functions for the major Johnson & Johnson franchises.
Johnson & Johnson Merck Consumer Pharmaceuticals Co. is a U.S.-based 50/50 joint
venture formed to develop and market nonprescription products derived primarily from
Merck & Co., Inc. prescription medicines, as well as products licensed and acquired from
outside sources. Current products include: Maximum Strength and Regular Strength
PEPCID®AC Acid Controller, for both the prevention and relief of heartburn and acid
indigestion; PEPCID®Complete, a combination acid controller and antacid; and anti-gas
products MYLANTA®Antacid and Infants’ MYLICON®Drops.
PRINCIPAL GLOBAL BUSINESSES PAGE 69
www.independencenow.com
www.pizbuin.com
www.johnsonsbaby.com
www.jjdevcorp.com
www.jnjgateway.com
www.jnj-merck.com
www.janssen-cilag.com
www.jnjgateway.com
www.janssen.com